Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Remodulin
Remodulin
Novartis' Sandoz loses bid to break United Therapeutics' exclusive device deal for Remodulin
Fierce Pharma
Thu, 01/30/20 - 09:17 pm
Novartis
Sandoz
United Therapeutics
Remodulin
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
BioSpace
Fri, 04/19/19 - 05:53 pm
United Therapeutics
PAH
Remodulin
generics
Sandoz
Medtronic wins FDA nod to deliver PAH therapy with implantable pump
Drug Delivery Business News
Tue, 07/31/18 - 09:57 am
Medtronic
FDA
drug delivery
United Therapeutics
PAH
Remodulin
devices
SynchroMed II
How Is United Therapeutics’ Remodulin Positioned in 2017?
Market Realist
Mon, 07/3/17 - 09:46 am
United Therapeutics
Remodulin
PAH
pulmonary arterial hypertension
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Sun, 11/20/16 - 05:37 pm
Medicare
H.P. Acthar Gel
Mallinckrodt
Remodulin
United Therapeutics
Tyvaso
Provenge
Valeant Pharmaceuticals
Gilead Sciences
Harvoni
United Therapeutics rises as court upholds patent protecting Remodulin, its top-selling drug
Yahoo/AP
Fri, 08/29/14 - 02:42 pm
United Therapeutics
patents
Remodulin
Did One Of The Top 10 Upside Surprises In The History Of The Biotech Sector Just Happen?
Forbes
Mon, 12/23/13 - 10:22 am
Remodulin
PAH
pulmonary arterial hypertension
Orenitram
United Therapeutics
United Therapeutics receives subpoena for 3 drugs
Yahoo/AP
Mon, 12/9/13 - 10:09 am
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
pulmonary arterial hypertension
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tue, 04/30/13 - 08:37 am
United Therapeutics
PAH
pulmonary arterial hypertension
Remodulin
Pluristem Therapeutics
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
United Therapeutics Falls as FDA Rejects Oral Remodulin
Bloomberg
Wed, 10/24/12 - 11:43 am
FDA
Remodulin
United Therapeutics
PAH
United Therapeutics Could Lose The Battle For PAH Therapies
TheStreet.com
Mon, 10/22/12 - 10:57 am
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
UTHR Files Suit vs. Sandoz
Yahoo/Zacks
Sat, 03/17/12 - 10:53 am
United Therapeutics
Sandoz
Novartis
generics
Remodulin
United Therapeutics sues Sandoz over hypertension drug
Reuters
Thu, 03/15/12 - 10:39 am
Sandoz
generics
lawsuits
United Therapeutics
Remodulin
pulmonary hypertension
United Therapeutics Grows With Drugs For Rare Diseases
Investors.com
Fri, 02/4/11 - 11:37 am
United Therapeutics
Remodulin
Adcirca
Tyvaso
PAH
United Therapeutics faces likely delay on FDA review for inhaled hypertension treatment
Yahoo/AP
Mon, 03/16/09 - 09:26 am
United Therapeutics
FDA
hypertension
Remodulin